Lichtenberg Michael
Angiology Clinic, Klinikum Hochsauerland GmbH Karolinen Hospital, Arnsberg, Deutschland.
Dtsch Med Wochenschr. 2022 Jun;147(11):650-656. doi: 10.1055/a-1828-4572. Epub 2022 May 30.
Deep vein thrombosis (DVT) is associated with a high cost burden for health care systems because of secondary cost intensive complications like pulmonary embolism and especially the post thrombotic syndrome (PTS). Current standard therapy of anticoagulation for DVT therapy has not changed through the years leaving patients especially with iliofemoral vein thrombus on a high-risk situation for developing PTS. For patients with chronic venous outflow obstruction of the iliac vein system dedicated venous stents and recanalization techniques are today available.
深静脉血栓形成(DVT)给医疗保健系统带来了高昂的成本负担,因为它会引发诸如肺栓塞等继发性高成本并发症,尤其是血栓后综合征(PTS)。多年来,DVT治疗的当前标准抗凝疗法并未改变,这使得患者,尤其是患有髂股静脉血栓的患者,面临发生PTS的高风险。如今,对于患有髂静脉系统慢性静脉流出道梗阻的患者,可以采用专用的静脉支架和再通技术。